Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-04-07

FDA Approved: NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) — Original Application (Creekwood Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved Creekwood Pharmaceuticals LLC's generic nitrofurantoin monohydrate/macrocrystals through an original ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nitrofurantoin (monohydrate/macrocrystals) (Nitrofurantoin monohydrate/macrocystals)

Snippet

ORIG AP for NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) (NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS))